These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32100113)

  • 21. Colorectal cancer in patients with type 2 diabetes mellitus: a single-center experience.
    Sinagra E; Guarnotta V; Raimondo D; Mocciaro F; Dolcimascolo S; Rizzolo CA; Puccia F; Maltese N; Citarrella R; Messina M; Spada M; Tomasello G; Cappello F; Leone A; Rossi F; Di Mitri R; Morreale GC; Marasà S; Midiri M; Midiri F; Sinagra D
    J Biol Regul Homeost Agents; 2017; 31(4):1101-1107. PubMed ID: 29254321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
    Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
    Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
    Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
    Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
    Zhang H; Gao C; Fang L; Zhao HC; Yao SK
    Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin use is not associated with colorectal cancer incidence in type-2 diabetes patients: evidence from methods that avoid immortal time bias.
    Zhang HS; Yang Y; Lee S; Park S; Nam CM; Jee SH
    Int J Colorectal Dis; 2022 Aug; 37(8):1827-1834. PubMed ID: 35831458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
    Xie H; Li M; Zheng Y
    Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
    Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
    Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
    Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
    Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
    Wahlqvist ML; Lee MS; Hsu CC; Chuang SY; Lee JT; Tsai HN
    Parkinsonism Relat Disord; 2012 Jul; 18(6):753-8. PubMed ID: 22498320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
    Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH
    Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure.
    Retwiński A; Kosmalski M; Crespo-Leiro M; Maggioni A; Opolski G; Ponikowski P; Poloński L; Jankowska E; Drzewoski J; Drożdż J
    Kardiol Pol; 2018; 76(9):1336-1343. PubMed ID: 29862487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.
    Cossor FI; Adams-Campbell LL; Chlebowski RT; Gunter MJ; Johnson K; Martell RE; McTiernan A; Simon MS; Rohan T; Wallace RB; Paulus JK
    Cancer Epidemiol; 2013 Oct; 37(5):742-9. PubMed ID: 23773299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients.
    Wang R; Liu R; Zhao L; Xu D; Hu L
    Rev Esp Enferm Dig; 2017 Jul; 109(7):503-509. PubMed ID: 28593781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.
    Jiang Y; Ben Q; Shen H; Lu W; Zhang Y; Zhu J
    Eur J Epidemiol; 2011 Nov; 26(11):863-76. PubMed ID: 21938478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
    Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
    Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.